Dynamics of susceptibility and transmissibility of the live, attenuated, candidate vaccines dengue-1 PDK13, dengue-3 PGMK30F3, and dengue-4 PDK48 after oral infection in Aedes aegypti.
Dengue-1 virus PDK13 and isolates from vaccinees (dengue-1 Ib1 and dengue-1 Ib 10), dengue-3 PGMK30F3, and dengue-4 PDK48 were studied for their abilities to infect, disseminate, and replicate in Aedes aegypti mosquitoes by the oral route. In general, infection and dissemination rates were poorer for the vaccine compared with the parent viruses. The transmissibility was also lower for dengue-1 PDK13 than the parent virus, whereas it was not detected for isolates from vaccinees and dengue-3 PGMK30F3. Transmissibility of dengue-4 PDK48 was not determined because no dissemination occurred. Replication rates of vaccine strains were also found to be less efficient than the parent viruses. These imply that vaccination with the candidate vaccine is safe. Moreover, vector attenuation of vaccine viruses was consistent with its phenotypic markers of attenuation, which remained stable after a mosquito passage or after human and mosquito passage.
Jirakanjanakit
N
N
Center for Vaccine Development, Institute of Science and Technology for Development, Mahidol University at Salaya, Nakornpathom, Thailand.
Khin
M M
MM
Yoksan
S
S
Bhamarapravati
N
N
D000284:Administration, Oral; D000330:Aedes / Q000276:immunology / Q000821:virology*; D000818:Animals; D000956:Antigens, Viral / Q000032:analysis; D003715:Dengue / Q000276:immunology / Q000517:prevention & control / Q000635:transmission*; D003716:Dengue Virus / Q000254:growth & development / Q000276:immunology*; D004198:Disease Susceptibility; D005260:Female; D019085:Fluorescent Antibody Technique, Direct / Q000662:veterinary; D006801:Humans; D007114:Immunization; D007303:Insect Vectors / Q000276:immunology / Q000821:virology; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000276:immunology / Q000592:standards; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology / Q000592:standards*
D000956:Antigens, Viral; D014613:Vaccines, Attenuated; D014765:Viral Vaccines